Their eleven - step process provides evaluation, cleaning, documentation, and pet owner education to
provide safety and efficacy.
Not exact matches
These risks
and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral
and other programs; the risk that private
and public payers may be reluctant to
provide, or continue to
provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy
and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks
and rebates due to ongoing contracts
and future negotiations with commercial
and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments
and geographic regions
and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal
and state grant cycles which may not mirror patient demand
and may cause fluctuations in Gilead's earnings; market share
and price erosion caused by the introduction of generic versions of Viread
and Truvada, an uncertain global macroeconomic environment;
and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers
and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop
and commercialize cell therapies utilizing the zinc finger nuclease technology platform
and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new
and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians
and patients may not see advantages of these products over other therapies
and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology
and inflammation / respiratory programs;
safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620
and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues
and pre-tax earnings;
and other risks identified from time to time in Gilead's reports filed with the U.S. Securities
and Exchange Commission (the SEC).
RxAdvance's staff of experienced pharmacists
and care managers
provide plan sponsors with clinically - driven services focused on
safety,
efficacy,
and cost containment.
«The study results elucidate the molecular mechanisms underlying disease progression in multiple sclerosis models,
providing a basis for future clinical trials to determine
safety and efficacy of these chemical agents in humans with demyelinating disorders,» says Patrizia Casaccia, MD, PhD, Professor of Neuroscience, Genetics
and Genomic Sciences at Mount Sinai
and senior author of the study.
The documentation ranges across the whole spectrum of drug development: Investigators» brochures
provide information on all that is currently known about the medicine
and so need periodic updating; accurate
and concise protocols are required to ensure that trials are performed effectively; clinical trial reports (generally from phase II
and III studies) present the information gathered from the trials; higher level documents
provide summaries of
efficacy and safety data from clinical trial programmes; expert reports
provide critical interpretation of the results;
and response documents clarify any points that are not clear to the regulatory agencies or
provide additional analyses or supporting data for any items of concern.
«A successful vaccine requires a fine balance between
efficacy and safety — vaccines made from attenuated live viruses generally offer fast
and durable immunity, but sometimes with the trade - off of reduced
safety, whereas inactivated
and subunit viruses often
provide enhanced
safety but may require several doses initially
and periodic boosters.
Goldman says the IMI also
provides a platform for agencies such as the U.S. Food
and Drug Administration
and the European Medicines Agency to discuss novel regulatory approaches to getting drugs to patients quickly while ensuring
safety and efficacy.
«Further research is needed to
provide definitive evidence of the
safety and efficacy of Tdap immunization during pregnancy,» the authors write.
«Results described in this manuscript
provide a comprehensive characterization of the
efficacy of the PMO antisense platform against Marburg virus in nonhuman primates
and its
safety profile in humans,» Bavari said.
We have commenced a series of clinical trials designed to obtain
safety and efficacy data on Epidiolex to
provide to the FDA
and other regulatory authorities around the world, which is necessary to be considered for approval as a prescription medicine.
Its technology is expected to
provide major advantages in patient treatment
efficacy,
safety,
and manufacturing costs.
The authors concluded existing regulations governing stem cells «
provide an appropriate structure for ensuring the
safety and efficacy of the next generation of stem - cell - based products.»
Overall, SR - Tiget represents a multi-disciplinary research environment, which
provides a unique blend of scientific expertise in the development of innovative gene
and cell therapy strategies, access to relevant preclinical models to evaluate their
efficacy and safety, as well as competence in conducting early phase clinical trials.
Evidence of Bioidentical Hormone
Safety and Efficacy Below are listed some articles that will provide evidence - based medical research on the safety and efficacy of bioidentical hor
Safety and Efficacy Below are listed some articles that will provide evidence - based medical research on the safety and efficacy of bioidentical h
Efficacy Below are listed some articles that will
provide evidence - based medical research on the
safety and efficacy of bioidentical hor
safety and efficacy of bioidentical h
efficacy of bioidentical hormones:
Why bother when there are literally thousands of studies in support of the
safety and efficacy of a whole food plant based diet supplying what you're trying to supplement AND providing a clear benefit in reduced death and disea
and efficacy of a whole food plant based diet supplying what you're trying to supplement
AND providing a clear benefit in reduced death and disea
AND providing a clear benefit in reduced death
and disea
and disease.
[107] Establishing guidelines to assess
safety and efficacy of botanical supplement products, the European Medicines Agency
provided criteria for evaluating
and grading the quality of clinical research in preparing monographs about herbal supplements.
This
provides greater label transparency to prove the product's
safety and efficacy.
Maryland University of Integrative Health's Post-Baccalaureate Certificate in Medical Herbalism
provides a foundational knowledge of herbal medicine that emphasizes issues of quality,
safety,
and efficacy.
Kiefer said that veterinarians should consider the following before working with companies that offer stem cells: what data they have
provided demonstrating the
efficacy and safety of their product, whether they rely on publications by other companies or groups
and whether their product is an equivalent product.
Their eleven - step process
provides evaluation, cleaning, documentation,
and pet owner education to promote
safety and efficacy.
While many of the participants raised concerns about the
efficacy and safety of large - scale iron fertilization, others seemed to acknowledge that the urgency of the climate crisis warranted the continuation of carefully designed experiments — pointing out that, if done appropriately, they could
provide a win - win for both scientists
and businesses interested in selling carbon offsets.
Prepare solicitations
and provide technical review (including
safety and efficacy data) of proposals for avian influenza, classical swine fever, Rift valley fever,
and other vaccines.